BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 3338061)

  • 1. Evaluation of the malignant grade of thymoma by morphometric analysis.
    Nomori H; Horinouchi H; Kaseda S; Ishihara T; Torikata C
    Cancer; 1988 Mar; 61(5):982-8. PubMed ID: 3338061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant grading of cortical and medullary differentiated thymoma by morphometric analysis.
    Nomori H; Ishihara T; Torikata C
    Cancer; 1989 Oct; 64(8):1694-9. PubMed ID: 2676138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological Findings in Myasthenia Gravis Patients with Thymic Hyperplasia and Thymoma.
    Chen P; Wang YP; Mou DL; Li ZY; Qu QM; Wang HY; Deng Y; Li XF; Wang T; Xu XH; Zhao G
    Pathol Oncol Res; 2018 Jan; 24(1):67-74. PubMed ID: 28299711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cultures of human myasthenia gravis thymus and normal thymus. Studies of cell morphology, cell proliferative pattern and localization of alpha-bungarotoxin binding sites on cultured thymic cells.
    Matsumoto Y; Furuya A; Kobayashi T; Tsukagoshi H
    J Neurol Sci; 1986 Sep; 75(2):121-33. PubMed ID: 3760907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic diseases as revealed by a series of consecutive thymectomies and biopsies from the thymus.
    Sundström C
    Ups J Med Sci; 1976; 81(1):18-22. PubMed ID: 1273995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomorphologic features characteristic of tumor stages of thymomas.
    Baba M; Nomoto Y; Iyoda A; Saito H; Hiroshima K; Shibuya K; Haga Y; Hoshino H; Iizasa T; Horiuchi F; Fujisawa T
    Oncol Rep; 2001; 8(5):1139-43. PubMed ID: 11496331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphologic criteria for the diagnosis of thymic pathology in myasthenia].
    Rykov VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(7):73-8. PubMed ID: 7124229
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative ultrastructural studies on three thymic lesions.
    Kay S
    Arch Pathol; 1970 Nov; 90(5):416-22. PubMed ID: 4319983
    [No Abstract]   [Full Text] [Related]  

  • 9. Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.
    Kraus VB; Harden EA; Wittels B; Moore JO; Haynes BF
    Am J Pathol; 1988 Sep; 132(3):552-62. PubMed ID: 3261946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nodular hyperplasia of the thymic epithelium (so-called microscopic thymoma).
    Cornea R; Lazăr E; Dema A; Herman D
    Rom J Morphol Embryol; 2009; 50(4):729-31. PubMed ID: 19942974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus genome in thymoma and thymic lymphoid hyperplasia.
    McGuire LJ; Huang DP; Teoh R; Arnold M; Wong K; Lee JC
    Am J Pathol; 1988 Jun; 131(3):385-90. PubMed ID: 2837902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological aspects of malignant and benign thymic disorders.
    Müller-Hermelink HK; Marx A
    Ann Med; 1999 Oct; 31 Suppl 2():5-14. PubMed ID: 10574149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphometrical and immunohistochemical analysis of cortical and medullary thymoma: its correlation with invasiveness and association with myasthenia gravis].
    Nomori H; Ishihara T; Torikata C
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Jan; 38(1):93-100. PubMed ID: 1691772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of thymus in myasthenia gravis: from thymic hyperplasia to thymic tumor.
    Priola AM; Priola SM
    Clin Radiol; 2014 May; 69(5):e230-45. PubMed ID: 24581970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown.
    Chilosi M; Iannucci A; Fiore-Donati L; Tridente G; Pampanin M; Pizzolo G; Ritter M; Bofill M; Janossy G
    J Neuroimmunol; 1986 May; 11(3):191-204. PubMed ID: 3514666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymoma. Histologic subclassification is an independent prognostic factor.
    Quintanilla-Martinez L; Wilkins EW; Choi N; Efird J; Hug E; Harris NL
    Cancer; 1994 Jul; 74(2):606-17. PubMed ID: 8033040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro interleukin-1 (IL-1) production in thymic hyperplasia and thymoma from patients with myasthenia gravis.
    Aime C; Cohen-Kaminsky S; Berrih-Aknin S
    J Clin Immunol; 1991 Sep; 11(5):268-78. PubMed ID: 1795043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymoma--morphologic subclassification correlates with invasiveness and immunohistologic features: a study of 122 cases.
    Quintanilla-Martinez L; Wilkins EW; Ferry JA; Harris NL
    Hum Pathol; 1993 Sep; 24(9):958-69. PubMed ID: 8253462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymic hyperplasia and neoplasia: a review of current concepts.
    Levine GD; Rosai J
    Hum Pathol; 1978 Sep; 9(5):495-515. PubMed ID: 361541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological study of thymomas--correlation of histologic subtype to myasthenia gravis and prognosis.
    Sundaram C; Rajagopal P; Rakshak AD; Omprakash G; Das SM; Murthy JM
    Indian J Pathol Microbiol; 2003 Jul; 46(3):378-81. PubMed ID: 15025278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.